Pfizer (PFE) is looking to offload the remaining 7.3% it owns in Haleon through a share sale, according to media reports Tuesday.
Pfizer will reportedly sell about 662 million shares in Haleon to institutional investors with Haleon agreeing to buy $220 million worth of those shares, according to Reuters.
The shares will reportedly be priced via an accelerated bookbuilding process.
Pfizer and Haleon did not immediately respond to requests for comment from MT Newswires.
Price: 26.26, Change: +0.20, Percent Change: +0.79
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments